RDIF offers vaccine for adolescents aged 12-17 in India
Sputnik M is a new member of the Sputnik vaccines family
Sputnik M is a new member of the Sputnik vaccines family
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
The trial will be conducted across eight sites in Maharashtra
The company has to approach the DCGI for approval to commence the trials
Subscribe To Our Newsletter & Stay Updated